CRANEWARE PLC — Remuneration Information 2014

Sep 23, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3859S

Craneware plc

23 September 2014

Craneware plc

("Craneware" or the "Company")

Grant of Options

23 September 2014 - The Board of Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions of the US healthcare market, announces that on 22 September 2014, the Remuneration Committee approved the granting of share options to certain Directors to subscribe for ordinary shares of 1p each in the Company as follows:

Director	No. of options granted	Percentage of issued share capital
Keith Neilson (Chief Executive Officer)	39,090	0.15
Craig Preston (Chief Financial Officer)	36,808	0.14

The above options have been granted at an exercise price of 522.5p per share (being the closing market price on 22 September 2014). These options will be subject to performance criteria, such that they vest in three equal tranches over three years. One third of the share options will vest on or after 30 June 2015, one third on or after 30 June 2016 and the final third on or after 30 June 2017. The share options will not become exercisable until three years from the date of the grant.

For further information, please contact:

Craneware plc	Peel Hunt	Newgate Threadneedle
+44 (0)131 550 3100	+44 (0)20 7418 8900	+44 (0)20 7653 9850
Keith Neilson, CEO	Dan Webster	Caroline Forde
Craig Preston, CFO	Richard Kauffer	Tim Thompson Heather Armstrong Edward Treadwell

About Craneware

Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEAFNDAFPLEFF